The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  March 2019 Next
  • Fragments 2019: 7th RSC-BMCS Fragment-Based Drug Discovery Meeting

    March 24-26, 2019   Cambridge, United Kingdom

    The aim of the 7th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.


    • John Barker, Evotec, United Kingdom
    • Paul Brennan, Structural Genomics Consortium, University of Oxford, United Kingdom
    • Jacob Bush, GlaxoSmithKline, United Kingdom
    • Rob Cooke, Sosei Heptares, United Kingdom
    • Benjamin Cravatt, The Scripps Research Institute, United States
    • Harren Jhoti, Astex Pharmaceuticals, United Kingdom
    • Roderick Hubbard, University of York and Vernalis, United Kingdom
    • György M Keseru, Hungary Academy of Sciences, Hungary
    • Dirk Kessler, Boehringer Ingelheim, Austria
    • Andras Kotschy, Servier Research Institute of Medicinal Chemistry, France
    • Mauro Marigo, Lundbeck, Denmark
    • Darryl McConnell, Boehringer Ingelheim, Austria
    • Christian Ottmann, University of Eindhoven, Netherlands
    • Andreas Ritzén, LEO Pharma, Denmark
    • Payal Sheth, Merck, United States
    • Ed Tate, Imperial College London, United Kingdom
    • Alison Woolford, Astex Pharmaceuticals, United Kingdom
    • Yafeng Xue, AstraZeneca, United States

    Early Bird Registration Deadline: January 21, 2019

    Poster abstract and Bursary application deadline: February 1, 2019

    Standard Registration Deadline: February 22, 2019

    Contact person: Mrs Maggi Churchouse
    Tel: +44 (0)1359 221004

25 26 27 28 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
01 02 03 04 05 06 07
All events   |  Future events

Job portal

Life Science Business Development Manager Europe Asia, Hybrigenics Services SAS: Business Development Europe Asia, Paris or European city, France
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRocheSanofiGalChimia
Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerckAstra ZenecaIdorsiaMercachemsyncom